Grant Sweep

Consolidated research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenR21Clinical trial: Not allowed

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

National Institutes of Health (NIH) · NIH Institute/Center · PAR-25-256

Source: Grants.gov · View original posting ↗

Award
Amount not listed
Deadline
Jan 7, 2027
Letter of intent
Mechanism
R21
Duration
Expected awards
Funding cycle
Standard NIH dates
Open date
Nov 15, 2024
Total funding
Clinical trial
Not allowed
Higher educationNonprofitSmall businessGovernmentForeign entities

Funding context

16%of applications funded

Based on FY2024 NIH (all institutes) R21 applications (1,837 of 11,592 applications awarded).

Institute-specific data wasn’t available — showing the NIH-wide rate for this mechanism.

Payline: NIH discontinued percentile paylines for 2026 under its Unified Funding Strategy ↗ — scores are now weighed in context rather than against a fixed cutoff.

NIH-wide R21, all institutes.

Aggregate historical data by institute, mechanism, and fiscal year — context for planning, not a prediction for this opportunity. Source ↗

Description

The goal of this NOFO is to support R21 applications for novel theory and methods development that better delineate how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary across the natural and social sciences, account for interdependencies across scales of biological, social, and ecological organization, and make extensive use of theory, simulations, and validation using available large-scale datasets

Data notes: award amount not published in the source feed; administering NIH institute could not be identified from the opportunity number.